Costantino John R 4
4 · ARTES MEDICAL INC · Filed Sep 29, 2008
Insider Transaction Report
Form 4
Costantino John R
Director
Transactions
- Award
Warrant (Right to Purchase Common Stock)
2008-09-26+89,292→ 89,292 total(indirect: By NGN BioMed Opportunity I, L.P.)Exercise: $0.75From: 2009-03-26Exp: 2014-03-26→ Common Stock (89,292 underlying) - Purchase
Common Stock
2008-09-26$0.81/sh+129,107$104,899→ 522,378 total(indirect: By NGN BioMed Opportunity I GmbH & Co. Beteiligungs KG) - Purchase
Common Stock
2008-09-26$0.81/sh+178,584$145,100→ 722,566 total(indirect: By NGN BioMed Opportunity I, L.P.) - Award
Warrant (Right to Purchase Common Stock)
2008-09-26+64,554→ 64,554 total(indirect: By NGN BioMed Opportunity I GmbH & Co. Beteiligungs KG)Exercise: $0.75From: 2009-03-26Exp: 2014-03-26→ Common Stock (64,554 underlying)
Footnotes (3)
- [F1]Represents total amount of common stock owned directly by NGN BioMed Opportunity I GmbH & Co. Beteiligungs KG.
- [F2]Mr. Costantino is the Managing General Partner of NGN Capital LLC. NGN Capital LLC is the managing limited partner of NGN BioMed Opportunity I, GmbH & Co. Beteiligungs KG and the sole general partner of NGN BioMed I, GP, L.P, the sole general partner of NGN BioMed Opportunity I, L.P. Mr. Costantino disclaims beneficial ownership of the securities held directly by NGN BioMed Opportunity I, GmbH & Co. Beteiligungs KG, NGN BioMed Opportunity I, L.P. and NGN Capital LLC except to the extent of any indirect pecuniary interest in his distributive share therein.
- [F3]Represents total amount of common stock owned directly by NGN BioMed Opportunity I, L.P.